Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Nkx2.2 Blocking Peptide (AC1284)
Cat.#: ACPP-1284
Specifications
Despition Nkx2.2 Blocking Peptide for Immunocompetition, Immunodepletion SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1803 Human KISS1 Protein (AC1803) 2 µg inquiry ACPP-1120 Human NRG1 Protein (AC1120) 10 µg inquiry ACPP-1507 Human SDC4 Protein (AC1507) 2 µg inquiry ACPP-1499 Mouse RAPSN Protein (AC1499) 5 µg inquiry ACPP-1569 Human SOX2 Protein (AC1569) 5 µg inquiry ACPP-1039 Recombinant Human FGFR4 Protein (6×His Tag) (AC1039) 50 µg inquiry ACPP-1534 Human RLN3 Protein (AC1534) 5 µg inquiry ACPP-1308 TrkA Blocking Peptide (AC1308) 250 µg inquiry ACPP-1108 Recombinant Human CD34 Protein (6×His Tag) (AC1108) 50 µg inquiry ACPP-1230 MC3 Receptor Blocking Peptide (AC1230) 250 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket